Nevertheless, glucose-dependent suppression of AMPK activity, likely to mimic the effect of Lkb1 deletion on mTOR activity, may provide a means through which changes in glycemia modulate the direction of the effect of TCF7L2 variants on type 2 diabetes risk. The gene discussed is STK11; the disease is type 2 diabetes mellitus.